In these 1-hour sessions, Maria Lundius and clinical pharmacologist Margreke Brill (QPS), will share QPS capabilities and experience in both conducting complex early phase clinical studies and supporting drug or asset development from the earliest phases of planning and development to later phase clinical trials and Regulatory submission.

Don’t miss this opportunity to discuss your clinical pharmacology and drug development questions over breakfast or lunch.

To facilitate an active discussion, space is limited to 10 people per session.

Attendees: 10 people per session maximum. Seats are limited. Please sign up early to secure your spot.

Format: QPS capabilities presentation, with Q&A and discussion during a light meal.

Join us :

9 March 2023 – 11:30 a.m,, 12:30 p.m. and 1:30 p.m. (lunch will be served) or
10 March 2023 – 08:30 a.m. and 9:30 a.m. (breakfast will be served)

To register: Contact Maria Lundius at maria.lundius@qps.com